Clinical Trials on NASH - Nonalcoholic Steatohepatitis in Hong Kong
Total 32 results
-
Humanity and Health Research CentreRecruitingNon-Alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steatohepatitis (NASH)Hong Kong
-
Chinese University of Hong KongNot yet recruitingNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Hong Kong
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Mexico, Puerto Rico
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Chinese University of Hong KongCompletedNonalcoholic Fatty Liver DiseaseChina
-
Chinese University of Hong KongCompletedNonalcoholic Fatty Liver DiseaseChina
-
Chinese University of Hong KongActive, not recruitingDiabetes Mellitus, Type 2 | Fatty Liver, NonalcoholicHong Kong
-
Chinese University of Hong KongCompletedNonalcoholic Fatty Liver DiseaseChina
-
Akero Therapeutics, IncRecruitingNASH With Fibrosis | MASH With FibrosisUnited States, Canada, Puerto Rico, Australia, India, France, Italy, Poland, Spain
-
Humanity and Health Research CentreRecruitingChronic Hepatitis B | Nonalcoholic Fatty Liver DiseaseChina
-
GenfitTerminatedNonalcoholic Steatohepatitis (NASH) With FibrosisUnited States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
-
HighTide Biopharma Pty LtdActive, not recruitingType 2 Diabetes | Nonalcoholic Steatohepatitis (NASH)United States, China, Hong Kong
-
Merck Sharp & Dohme LLCRecruitingNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, NonalcoholicCanada, United States, Puerto Rico, Israel, Japan, Korea, Republic of, Taiwan, Spain, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisHong Kong, United States, Australia, Puerto Rico, New Zealand, Canada
-
Boehringer IngelheimCompletedNon-alcoholic Steatohepatitis (NASH)United States, Spain, Korea, Republic of, United Kingdom, Australia, Canada, Singapore, Germany, Italy, Malaysia, China, France, Japan, Netherlands, Taiwan, Austria, Israel, New Zealand, Poland, Hong Kong, Belgium, Czechia, Greece, Hu... and more
-
Merck Sharp & Dohme LLCTerminatedNonalcoholic SteatohepatitisKorea, Republic of, United States, Argentina, Australia, Canada, Chile, China, Colombia, France, Germany, Greece, Hong Kong, Israel, Italy, Japan, Malaysia, Mexico, New Zealand, Puerto Rico, Russian Federation, Spain, Sweden, Taiwan, ...
-
Tobira Therapeutics, Inc.TerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Australia, France, Germany, Spain, Poland, United Kingdom, Italy, Puerto Rico, Belgium, Hong Kong
-
Tobira Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisBelgium, Spain, Hong Kong, United States, France, Germany, Australia, United Kingdom, Poland, Italy
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisHong Kong, United States, Spain, United Kingdom, Australia, Taiwan, Belgium, Canada, India, Japan, Korea, Republic of, Singapore, Puerto Rico, France, Israel, Austria, Germany, Italy, Malaysia, New Zealand, Mexico, Poland, Switzerland, Netherlan... and more
-
Zydus Therapeutics Inc.RecruitingFibrosis | Nonalcoholic SteatohepatitisUnited States, Turkey, Argentina
-
AstraZenecaAstraZeneca K.K.RecruitingNonalcoholic SteatohepatitisUnited States, China, Korea, Republic of, Germany, Japan, Spain, Vietnam, Argentina, Colombia, Peru, Brazil, Malaysia, Taiwan, Thailand, Italy, Turkey, Hong Kong, Singapore, India, Mexico, Chile, Philippines, Portugal
-
Gilead SciencesNovo Nordisk A/SActive, not recruitingNonalcoholic SteatohepatitisUnited States, Spain, Australia, France, Japan, Puerto Rico, Canada
-
Tobira Therapeutics, Inc.TerminatedNonalcoholic SteatohepatitisUnited States, Spain, Australia, Belgium, Israel, Canada, Puerto Rico, Italy, Germany, France, New Zealand, Taiwan, Poland, United Kingdom, Brazil, Austria, Singapore, Portugal, Chile, Greece, Hong Kong, Hungary, Latvia, Mexico, Norway, R... and more
-
Jong Keon JangCanon Medical Systems, KoreaRecruitingFatty Liver | Ultrasound | Fatty Liver, NonalcoholicKorea, Republic of
-
Sagimet Biosciences Inc.CompletedNonalcoholic Fatty Liver DiseaseUnited States, Canada, Puerto Rico, Poland
-
Galmed Research and Development, Ltd.Medical University of Graz; Tel-Aviv Sourasky Medical Center; Fondazione IRCCS... and other collaboratorsCompletedLiver Diseases | Fatty Liver | Non-Alcoholic Steatohepatitis | Liver FibrosesUnited States, Chile, Israel, Italy, France, Germany, Mexico, Georgia, Lithuania, Hong Kong, Romania
-
Yungjin Pharm. Co., Ltd.TerminatedNonalcoholic Fatty Liver DiseaseKorea, Republic of
-
Novo Nordisk A/SRecruitingNon-alcoholic SteatohepatitisUnited States, Korea, Republic of, Australia, Taiwan, Italy, Israel, Canada, Netherlands, Czechia, Malaysia, Spain, Denmark, China, United Kingdom, Singapore, Japan, Puerto Rico, Portugal, Switzerland, Ireland, Belgium, Romania, Ger... and more